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Abstract Glycopeptide enrichment is a crucial step in
glycoproteomics for which hydrophilic interaction chroma-
tography (HILIC) has extensively been applied due to its
low bias towards different glycan types. A systematic evalua-
tion of applicable HILIC mobile phases on glycopeptide en-
richment efficiency and selectivity is, to date, however, still
lacking. Here, we present a novel, simplified technique for
HILIC enrichment termed BDrop-HILIC^, which was applied
to systematically evaluate the mobile phase effect on ZIC-
HILIC (zwitterionic type of hydrophilic interaction chroma-
tography) glycopeptide enrichment. The four most commonly
used MS compatible organic solvents were investigated: (i)
acetonitrile, (ii) methanol, (iii) ethanol and (iv) isopropanol.
Glycopeptide enrichment efficiencies were evaluated for each
solvent system using samples of increasing complexity rang-
ing from well-defined synthetic glycopeptides spiked into dif-
ferent concentrations of tryptic BSA peptides, followed by
standard glycoproteins, and a complex sample derived from
human (depleted and non-depleted) serum. ZIC-HILIC glyco-
peptide efficiency largely relied upon the used solvent.
Different organic mobile phases enriched distinct
glycopeptide subsets in a peptide backbone hydrophilicity-
dependant manner. Acetonitrile provided the best compromise
for the retention of both hydrophilic and hydrophobic glyco-
peptides, whereas methanol was confirmed to be unsuitable
for this purpose. The enrichment efficiency of ethanol and
isopropanol towards highly hydrophobic glycopeptides was
compromised as considerable co-enrichment of unmodified
peptides occurred, though for some hydrophobic glycopep-
tides isopropanol showed the best enrichment properties.
This study shows that even minor differences in the peptide
backbone and solvent do significantly influence HILIC gly-
copeptide enrichment and need to be carefully considered
when employed for glycopeptide enrichment.
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Introduction
Protein glycosylation is one of the most common and func-
tionally diverse post-translational modifications. It is involved
in different processes such as cell–cell interaction and signal
recognition [1] and is an essential regulating factor of the
immune system [2–4]. Glycosylation is a non-template-
driven enzymatic process that also reflects the physiological
state of the cell [5, 6], and glycoprotein functions are dictated
by both glycans and their respective proteins. Thus, sensitive
and selective methods for primary structure sequencing of
glycoproteins are essential to understand and study the func-
tional significance of glycosylation. This integrated and sys-
tematic approach for compiling glycoprotein structure and
function is one major aim in glycoproteomics [7].
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Peptide and glycopeptide mixtures are frequently analysed
following proteolytic digestion by either LC-ESI-MS/MS or
MALDI-TOF-MS. However, simultaneous detection of pep-
tides and glycopeptides can be tricky. Glycoprotein proteoly-
sis often results in unequal mixtures of these compounds as
glycopeptide microheterogeneity reduces the concentration of
each individual glycopeptide molecule compared to unmodi-
fied peptides obtained by the same digest [8]. Hydrophobic
molecules also tend to provide stronger signals compared to
hydrophilic ones, which further complicates glycopeptide de-
tection in the presence of unmodified peptides [9].
Subsequently, glycopeptide signal strengths are significantly
lower compared to their unmodified counterparts, mostly due
to the presence of the large hydrophilic glycan moiety [10].
Therefore, glycopeptide enrichment is often performed to al-
low their detection and identification [11–13].
In contrast to glycopeptide enrichment methods using
lectins, hydrazide chemistry, titanium dioxide or graphitized
carbon, hydrophilic interaction chromatography (HILIC)
comes with the unique advantage to enable glycopeptide en-
richment in a largely glycan structure unbiased manner.
During the HILIC enrichment process, glycopeptides are also
not chemically or enzymatically altered: This is highly rele-
vant for in-depth glycoproteomics. Another significant advan-
tage of HILIC is that both peptide and glycan present in the
enriched fraction can be analysed in a high-throughput fashion
as intact glycopeptides but also individually after enzymatic
treatments with PNGase F/A.
In contrast to normal phase chromatography, the HILIC
retention mechanism is largely a result of a hydrophilic
partitioning of the analyte to the water-enriched layer sur-
rounding the polar stationary phase [14]. Glycopeptide reten-
tion mainly depends on the size of the glycan moiety and its
hydrophilic properties, but also on the hydrophilic features of
the peptide backbone. The polar interaction between the gly-
copeptides’ glycan moieties with the hydrophilic layer sur-
rounding the stationary phase provides an opportunity to sepa-
rate glycopeptides from (usually) less hydrophilic peptides.
Furthermore, depending upon the type of the used stationary
phase, hydrogen bonding, electrostatic or dipole–dipole inter-
actions also influence analyte retention [14, 15]. Awide range
of HILIC stationary phases have successfully been reported
for glycopeptide enrichment ranging from silica particles [16],
cellulose [17], sulfoalkylbetaine (ZIC-HILIC) [18, 19],
amide-based [20] to even simple cotton [21]. The excellent
review by Hemström and Irgum describes in detail the deve-
lopments in polar stationary phases and their retention mecha-
nisms [22]. More recently, also the suitability of several
chemically fabricated stationary phases has been reported for
glycopeptide enrichment [23–25].
Glycopeptide enrichment is usually performed at starting
conditions with 80% organic solvent concentration while elu-
tion is performed by disturbing the hydrophilic interactions
using aqueous conditions. Acetonitrile is by far the most pop-
ular organic mobile phase applied for this purpose [26].
Although HILIC SPE is efficient (reproducible and sensitive)
for glycopeptide enrichment from mixtures, hydrophilic non-
glycosylated peptides are also frequently co-enriched. This
represents a particular problem for analysing complex samples
as the co-enriched hydrophilic peptides can cause glycopep-
tide ion-suppression. Co-enrichment of hydrophilic non-
glycosylated peptides can, however, be avoided or at least
significantly reduced by the addition of suitable ion-pairing
reagents such as trifluoroacetic acid (TFA) or hydrochloric
acid (HCl) [27, 28]. Alternatively, the reduction of non-
specific enrichment has also been reported by digesting the
glycoprotein with non-specific proteases prior HILIC enrich-
ment. This greatly increases glycopeptide hydrophilicity due
to the shorter peptide backbone [29]. The drawbacks of this
approach are, however, increased sample heterogeneity, im-
peded accurate site specific glycan structure assignment and
lack of accurate relative quantitation of site specific microhet-
erogeneity [30].
Andrew Alpert once described HILIC as Bthe combination
of hydrophilic stationary phases and hydrophobic, mostly or-
ganic mobile phases^ [14]. Compared to other HILIC mate-
rials, ZIC-HILC is known to provide higher selectivity for
glycopeptides [31]. Therefore, in the present work, we sys-
tematically evaluated the effect various mobile phases [aceto-
nitrile (ACN), methanol (MeOH), ethanol (EtOH) and
isopropanol (IPA)] have on the selectivity and efficiency to
enrich glycopeptides using ZIC-HILIC. Glycopeptide enrich-
ment efficiencies were evaluated for each solvent system
using a variety of samples, which required the development
of an enrichment technique suitable for this purpose termed
BDrop-HILIC^. Drop-HILIC is significantly cheaper and
quicker to perform than the conventional micro-spin tech-
nique and provides comparable results. Different purified gly-
coproteins as well as more complex samples provided in the
form of depleted and non-depleted human serum were tested
to conclude that glycopeptide enrichment efficiency largely
depends on the organic mobile phase.
Materials and methods
Materials
If not otherwise stated, all materials were purchased in the
highest possible quality from Sigma-Aldrich (St. Louis, MO,
USA). Trypsin (sequencing grade) was obtained from Roche
Diagnostic GmbH (Mannheim, Germany). Water was used
after purification with a Milli Q-8 direct system (Merck
KGaA, Darmstadt, Germany). IgG (I4506) and A1PI
(A6150) were obtained from Sigma-Aldrich. Human serum
was obtained from BioreclamationIVT (New York, USA).
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The amino acid numbering applied for all proteins analysed in
this study is based on the respective UniProtKB entries.
High abundance serum protein depletion
Depletion of abundant serum proteins was performed accord-
ing to the manufactures instructions using a commercially
available kit (ProteoSpin™ Abundant Serum Protein
Depletion Kit Cat. # 17300).
In-solution protease digestion
One hundred micrograms of protein [IgG, A1PI or serum
(depleted and non-depleted)] was reduced with 10 μL of
500 mM dithiothreitol (DTT) (in H2O) (99 °C, 5 min) and
then subsequently alkylated with 10 μL 500 mM
iodoacetamide (IAA) solution (in H2O) at room temperature
for 60 min in the dark. Prior trypsin digestion, the samples
were subjected to chloroform-methanol precipitation as de-
scribed earlier [32]. The protein pellet was resolubilised in
200 μL of 25mMNH4HCO3 and trypsin added in a 1:30 ratio
(enzyme:substrate). After overnight incubation at 37 °C, the
resulting glycopeptide/peptide mixtures were aliquoted corre-
sponding to 3 μg of initial protein concentration and dried in
the speedvac without additional heating. The samples were
stored at −25 °C until further experiments.
HILIC enrichment—micro-spin
ZIC-HILIC (pore size 200 Å, 10 μm particle size, SeQuant
AB, Sweden) was filled up to 1.5 cm in a C18 ZipTip P10
(Merck Millipore, Tullagreen, IRL). The column was washed
three times with 50 μL of 1% TFA and then equilibrated three
times with 50 μL of 80%ACN containing 1% TFA. The dried
sample was reconstituted in 10 μL 1% TFA and slowly ad-
justed to 80% ACN/1% TFA by the addition of 40 μL ACN/
1% TFA. The sample was applied onto the column and cen-
trifuged until the entire liquid passed through. The
flowthrough was reapplied onto the column and again centri-
fuged. The sample was washed twice with 50 μL of 80%
ACN containing 1% TFA and glycopeptides were eluted off
the column by washing it thrice with 50 μL of 1% TFA
followed by 50 μL of 80% ACN containing 1% TFA. The
eluted fraction was dried in the speedvac and reconstituted in
50 μL of 0.1% TFA for further MS analyses. All analyses
were performed in triplicate.
HILIC enrichment—BDrop-HILIC^
Tryptic protein digests were dissolved in 10 μL 1% TFA and
slowly adjusted to 80% organic solvent conditions by the ad-
dition of 40 μL organic solvent (ACN/1% TFA or EtOH/1%
TFA or MeOH/1% TFA or IPA/1% TFA). ZIC-HILIC beads
were washed three times with 1% TFA (3× 250 μL) and then
equilibrated three times with appropriate binding solution (3×
250 μL). Subsequently, the HILIC beads were added to the
sample and incubated at room temperature for 1, 3 or 5 min
with occasional shaking. After incubation, the HILIC beads
were spun down in a table centrifuge. The supernatants
(flowthrough) were transferred into a new vial. The HILIC
beads were then mixed with 50 μL appropriate binding solu-
tion, vortexed and spun down. The supernatants were pooled
together, and the washing step was repeated twice. Enriched
glycopeptides were eluted using 3× 50μL of the elution buffer
(1% TFA), and all three elution supernatants were combined
in a new vial. The eluate was dried in the speedvac and
reconstituted in 50 μL of 0.1% TFA for further MS analyses.
All analyses were performed in triplicate.
Glycopeptide synthesis
Solid phase glycopeptide synthesis (SPGPS) was performed
manually using 5 and 10-mL disposable polypropylene syrin-
ges with a bottom filter. All peptides and glycopeptides were
synthesised by SPGPS using previously reported
fluorenylmethoxycarbonyl (Fmoc) protocols [10, 33, 34]
and as described in detail in the Electronic Supplementary
Material (ESM).
LC-MS analysis parameters
Nano-LC-ESI-MS analysis was carried out on an Ultimate
3000 RSLC-nano system (Dionex/Thermo Scientific,
Sunnyvale, CA) coupled to an amaZon speed ETD ion trap
mass spectrometer (IT-MS) equipped with CaptiveSpray
nanoBooster™ (both Bruker, Bremen, Germany). In each
run, glycopeptides corresponding to 180 ng were injected.
In nano-LCmode, the peptides were concentrated on a C18
precolumn (Acclaim PepMap100™, Thermo, 100 μm ×
20 mm, 5 μm particle size) and separated by reversed phase
chromatography on a C18 analytical column (Acclaim
PepMap™, Thermo, 75 μm × 15 cm, 3 μm particle size).
The samples were loaded in 99% loading buffer (0.1% TFA)
for 5 min on the precolumn at a flow rate of 5 μL/min before
the captured peptides were subjected to reversed phase
nanoLC at a flowrate of 400 nL/min on a column equilibrated
in 95% buffer A (0.1% formic acid). The gradient conditions
were as follows: increase of buffer B (90% acetonitrile con-
taining 0.1% formic acid) from 5 to 45% (6–36 min), further
increase to 70%B (36–38min), followed by a steeper increase
to 90% B (40–42 min). The column was held at 90% B for
10 min (42–52 min). The mass spectrometer was set up to
perform CID on the three most intense signals in every MS
scan. An m/z range from 400 to 1600 Da was used for data-
dependent precursor scanning. The MS data was recorded
using the instrument’s Benhanced resolution mode^. MS/MS
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data was acquired in Bultra-mode^ over anm/z range from 100
to 2000. A detailed parameter setting is provided in ESM
Table S1 following MIRAGE [35] and MIPAE [36]
recommendations.
Data analysis was performed using ProteinScape 3 (Bruker
Daltonics) and MASCOT 2.3 (MatrixScience, United
Kingdom) using the following search parameters: Cysteine
as carbamidomethyl was set as fixed modification, and
deamidation (Asn/Gln) and oxidation (Met) were set as vari-
able modifications. Up to twomissed cleavages were allowed.
Peptide tolerance was set at ±0.3 Da for MS and at ±0.5 Da for
MS/MS. The data were searched against the SwissProt protein
database (taxonomy restriction: Homo sapiens, SwissProt
2011_08; 531,473 sequences; 188,463,640 residues).
Results and discussion
Rationale and experiment design
The efficiency and selectivity of glycopeptide enrichment by
ZIC-HILIC SPEwere first investigated using well-defined syn-
thetic glycopeptides spiked into different concentrations of
tryptic peptides derived from BSA. Following these initial ex-
periments, HILICwas performed on proteolytic digests of stan-
dard glycoproteins (IgG and A1PI) and finally applied on a
complex sample derived from human serum (Fig. 1). The in-
fluence of the mobile phase on glycopeptide enrichment effi-
ciency was tested using four different solvents: (i) acetonitrile,
(ii) methanol, (iii) ethanol and (iv) isopropanol were used at a
concentration of 80% in water containing 1% TFA as an acidic
modifier. In the course of this work, we also evaluated a sim-
plified HILIC enrichment technique (BDrop-HILIC^) and com-
pared it to the traditional micro-spin HILIC approach.
Salt removal is crucial for efficient HILIC enrichment
Initial experiments applying the micro-spin method to enrich
IgG glycopeptides resulted in no/insufficient enrichment
when performed subsequently following in-solution trypsin
digestion (data not shown). Applying this workflow directly
on in-gel digested (glyco)peptides, however, provided the ex-
pected results. We found that the residual presence of higher
salt concentrations derived from the alkylating reagents result-
ed in electrostatic (ionic) interactions that were compromising
glycopeptide enrichment when performed subsequently after
an in-solution proteolytic digest. A simple reversed phase-
based desalting step could be introduced prior HILIC. This
step, however, can also lead to the loss of very hydrophilic
glycopeptides [37]. To avoid such losses, we modified our in-
solution sample preparation protocol by introducing a simple
chloroform–methanol precipitation step immediately after re-
duction and alkylation to remove any excess DTT and IAA.
This simple, fast and efficient step allowed us to successfully
enrich glycopeptides, greatly minimise sample losses and
eliminate any molecules affecting the enrichment efficiency.
These optimised proteolytic sample preparation conditions
were then applied for all following experiments.
Fig. 1 Experiment design.
Investigating the influence of
various organic mobile phases on
ZIC-HILIC glycopeptide
enrichment efficiency and
development of a simplified
HILIC enrichment technique
(BDrop-HILIC^). All four mobile
phases [(i) acetonitrile, (ii)
ethanol, (iii) methanol and (iv)
isopropanol] were tested using
80% organic solvent starting
conditions. Glycopeptide
enrichment efficiencies were
evaluated by nanoLC ESI-MS/
MS using samples of increasing
complexity ranging from well-
defined synthetic glycopeptides
spiked into a tryptic digest of
BSA over individual standard
glycoproteins to a tryptic digest of
depleted and non-depleted human
serum
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Same, same but different: to spin or to BDrop-HILIC^
Using acetonitrile loading solvent conditions in our hands, the
sample required approximately 3–5 min to pass through the
ZIC-HILICmicro-spin column. However, when applyingmore
viscous solvents such as isopropanol up to 20 min were re-
quired. As we intended to evaluate the influence of various
organic mobile phases on the glycopeptide enrichment, we
established a simplified and accelerated technique by simply
co-incubating the sample with the HILIC beads, termed BDrop-
HILIC^. This approach provided the opportunity to normalise
incubation times and evaluate any solvent effect, which could
not reasonably be achieved by the micro-spin HILIC method.
Besides being easier and quicker to perform, Drop-HILIC pro-
vided additional advantages: (i) the amount of HILIC material
could be optimised to accommodate variable sample amounts
and (ii) it was more cost and time effective as no C18 Zip-tip
columns or custom made tips were required.
We first compared the micro-spin and Drop-HILIC ap-
proaches using two well-characterised standard glycoproteins,
human IgG and A1PI using 80% acetonitrile loading solvent
conditions. The glycopeptide enriched fractions were subse-
quently analysed by nanoLC-ESI-MSMS (Fig. 2, ESM
Tables S2 and S3). Both techniques yielded comparable IgG
glycopeptide profiles (Fig. 2a). IgG2 provided the most abun-
dant signals followed by the glycopeptides derived from IgG1
and IgG4. However, a slightly different trend was observed in
the case of A1PI. The drop approach enriched glycopeptides
A1PI-GP3 (268YLGNATAIFFLPDEGK283) significantly bet-
ter. On the other hand, glycopeptides containing a larger pep-
tide backbone (A1PI-GP4 carrying H5N4F0Na2 and
H3N3F0Na1 as well as A1PI-GP1) were not enriched with
similar efficiency (Fig. 2b). In order to evaluate whether the
one-minute incubation time affects Drop-HILIC enrichment
efficiency for these larger glycopeptides, possibly due to in-
adequate phase partitioning, we additionally tested various
incubation times.
Incubation Time Does Not Influence Drop-HILIC
Enrichment Efficiency
Various incubation times (1, 3 and 5 min) did not show any
significant changes in the enrichment efficiency of IgG glyco-
peptides under standard conditions. Longer incubation times
did also not improve the enrichment of the larger hydrophobic
A1PI glycopeptides, indicating that the Drop-HILIC approach
exhibited some limitations for efficiently enriching such large,
>25 amino acid long, comparably hydrophobic glycopeptides.
Despite these observed limitations the Drop-HILIC approach
provided glyco-profile results comparable to the classical
micro-spin HILIC method for IgG and A1PI-GP3 (ESM
Fig. S1). Drop-HILIC, however, came with the advantages
of being significantly quicker and cheaper to perform. As
the incubation time did not show any influence on the enrich-
ment efficiency all further experiments were performed using
1 min incubation times for the evaluation of any effect the
organic mobile phase has on glycopeptide enrichment
efficiency.
It is all about the solvent—influence of the solvent system
on ZIC-HILIC glycopeptide enrichment
The underlying mechanism of analyte retention in ZIC-HILIC
is originating from hydrophilic partitioning in addition to con-
tributions derived from minor electrostatic interactions. The
use of TFA in the mobile phase nullifies any possible electro-
static interactions making hydrophilic partitioning the only
cause for analyte retention [28]. For an efficient enrichment,
the ideal mobile phase should be water miscible, but not con-
tribute any hydrogen donor or acceptor functionalities. A
completely aprotic solvent such as acetonitrile embraces this
particular feature and thus is often used for glycopeptide en-
richment by HILIC SPE. However, a systematic evaluation of
any mobile phase effect on glycopeptide enrichment is still
lacking. The optimised sample preparation step in combina-
tion with our simple, fast and equally efficient Drop-HILIC
approach allowed us to evaluate the influence of various MS
compatible mobile phase solvents on ZIC-HILIC glycopep-
tide enrichment efficiency.
First, we evaluated the solvent effect in a defined system
using glycoform-specific syntheticN-glycopeptides spiked in-
to the background of tryptically digested BSA (please refer
ESM – Glycopeptide synthesis section). The synthetic glyco-
peptides corresponded to the tryptic glycopeptide sequences
present in IgG1, IgG2 and IgG3 and carried a bianntenary,
disialylated N-glycan (Fig. 1). These compounds were mixed
with tryptic BSA derived peptides in molar ratios 3:1:1:3
(IgG1/IgG2/IgG3/BSA), and glycopeptide enrichment was
performed using the Drop-HILIC technique. Our initial results
indicated that methanol is a non-favoured mobile phase for
this purpose (data not shown). Due to its strong tendencies
to form hydrogen bonds, methanol effectively competes for
the active sites on the stationary phase and is thereby
perturbing hydrophilic partitioning. This subsequently result-
ed in strongly reduced glycopeptide retention and thus was not
further evaluated [38]. The glycopeptide-enriched fractions
from the other solvents (ACN, EtOH, IPA), however, were
analysed by RP-nano LC-ESI-IT-MSMS.
We observed a mobile phase solvent dependency in the
selectivity and efficiency for glycopeptide enrichment
(Fig. 3a), which was also considerably influenced by the hy-
drophilicity of the peptide backbone (ESM Table S2). The
synthetic IgG1 glycopeptide was efficiently enriched in a sim-
ilar manner by all three solvents, while a strong mobile phase
dependency was observed for IgG2 and IgG3 synthetic gly-
copeptides. Ethanol significantly enriched the synthetic IgG3
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(75.43 ± 8.42%) and IgG2 (88.58 ± 6.76%) glycopeptides bet-
ter than ACN or IPAwhile the IgG2 glycopeptide could not be
enriched at all using IPA in the background of tryptic BSA
peptides (Fig. 3a). Interestingly, this peptide is also the most
hydrophobic of the three synthetic N-glycopeptides (GRAVY
score of −1.60, see also ESM Table S4). The data suggested
that either the hydrophilic BSA peptides outcompeted the
IgG2 synthetic N-glycopeptide or suppressed its ionisation,
making it not detectable under the used conditions. When
excess molar ratios of BSA were applied (IgG1/IgG2/IgG3/
BSA = 3:1:1:6 and 3:1:1:10), glycopeptide enrichment effi-
ciency was compromised especially in the case of EtOH and
IPA as the abundances of co-enriched peptides clearly in-
creased (ESM Fig. S4). Under the tested conditions, ACN
provided the best compromise for the retention of all three
synthetic glycopeptides while keeping the number of co-
enriched BSA peptides at a low level. Nevertheless, with all
three mobile phases, numerous peptides were co-enriched in a
mobile phase dependent manner (Fig. 3b, ESM Table S5).
Inspired from these results, we next studied the loading
solvent influence on ZIC-HILIC glycopeptide enrichment
using individual standard glycoprotein digests of IgG and
A1PI. Also for these low-complex samples, a loading
solvent-dependant selectivity was found. The human IgG gly-
copeptides showed similar results as obtained for the synthetic
ones, with the exception that IPA was a suitable solvent to
enrich the IgG2 glycopeptide (Fig. 3c), indicating that the
BSA tryptic peptide background was interfering with its en-
richment in earlier experiments (Fig. 2a). In the case of A1PI,
however, isopropanol provided the best compromise for the
simultaneous enrichment of hydrophilic and hydrophobic gly-
copeptides (Fig. 3d). This can possibly be explained by the
fact that not all (glyco)peptides were equally soluble under
80% organic mobile phase conditions [39]. This hypothesis
was also supported by the different identified co-enriched un-
modified peptides that were found for the individual solvents
(ESM Table S6A-S6C, Fig. S5). As a consequence of this
insolubility, an insufficient enrichment of certain glycopeptide
Fig. 2 Glycoprofile comparison of the Drop-HILIC and micro-spin
techniques using ACN as mobile phase for glycopeptide enrichment
from (a) IgG and (b) A1PI. Enriched glycopeptides were analyzed by
RP-nanoLC-ESI-MSMS. IgG contains a single site of glycosylation
whereas three are present in A1PI. The relative abundances were
determined using the area under the curve of extracted ion
chromatograms (EIC’s) produced from all glycoform and charge state
signals detected for each single glycopeptide. Three technical replicates
were performed. Both techniques performed similar on IgG
glycopeptides, while some glycoprofile differences were found for the
hydrophobic A1PI glycopeptides
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Fig. 3 Loading solvent effect on ZIC-HILIC glycopeptide
enrichment. a Synthetic N-glycopeptides corresponding to IgG1,
IgG2 and IgG3 tryptic peptides were spiked into a tryptic digest
of BSA. Whereas ACN did effectively enrich all three isoforms,
EtOH and IPA exhibited IgG subclass specific tendencies. b Venn
diagram showing the number of BSA-derived peptides co-enriched
with the synthetic glycopeptides when using different loading
solvents. c, d Different mobile phases were used for loading the
(glyco)peptide mixtures onto the resin, resulting in a differential
enrichment of various glycopeptide species from (c) IgG and (d)
A1PI samples
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species was observed when using EtOH. Our results indicated
that analyte retention in HILIC was not just controlled by
hydrophilic partition but that more complex mechanisms oc-
curring prior sample loading and at the interface of the station-
ary polar and organic mobile phase during sample solvation
were also influencing enrichment efficiency.
Glycopeptide enrichment from human serum using
Drop-HILIC
Finally, glycopeptide enrichment from human serum before
and after depletion of the four most abundant proteins (albu-
min, A1PI, transferrin and haptoglobin) was evaluated. As
observed for the purified standard glycoproteins, the number
of enriched glycopeptides varied in a solvent dependant man-
ner (Fig. 4a–c; ESM Table S7). Glycopeptide enrichment ef-
ficiencies were determined taking the presence of identified
co-enriched, non-glycosylated peptides as an indicator, while
a simple automated glycopeptide classification feature avail-
able in the ProteinScape software tool was used to establish
the number of enriched glycopeptides. After manual verifica-
tion of the MSMS spectra for oxonium ions, just hits with a
minimum oxonium ion intensity score of ≥60 were considered
as glycopeptides.
A significant number of relatively low molecular weight,
non-glycosylated peptides (between 1000 and 2200 Da) were
frequently co-enriched. The degree of non-specific enrich-
ment of higher molecular weight peptides was found to largely
dependent on the used solvent (ESM Table S8). A high num-
ber of human serum albumin-derived peptides was co-
enriched by all loading solvents, but each solvent co-
enriched an individual peptide subset (Fig. 4d–f). The
enriched glycopeptide fractions were also treated with
PNGase F and analysed by RP-nano LC-ESI-MSMS to sim-
ply identify enriched, previously glycosylated peptides. The
use of acetonitrile, ethanol and isopropanol, respectively, as
loading solvent resulted in the identification of 26, 28 and 33
non-redundant, previously glycosylated peptides carrying the
deamidated N-glycosylation sequence motif. So despite the
fact that isopropanol also co-enriched the highest number of
unmodified peptides, it also provided the highest number of
glycopeptides. These results clearly emphasise that besides
(glyco)peptide hydrophilicity sample solvation plays an im-
portant role in ZIC-HILIC glycopeptide enrichment.
Conclusion
With Drop-HILIC a simple, fast and cost-effective optimised
sample pre-treatment and ZIC-HILIC glycopeptide enrich-
ment strategy was developed. This technique was applied to
evaluate the effect the loading solvent has on glycopeptide
enrichment efficiency. Independent of whether glycopeptides
were enriched from single, purified glycoproteins or complex
(glyco)peptide mixtures derived from human serum, ZIC-
HILIC glycopeptide enrichment efficiency largely relied on
Fig. 4 Loading solvent effect on ZIC-HILIC glycopeptide enrichment
from (a) the four depleted high abundance proteins (b) depleted human
serum (c) un-depleted serum. Depending upon the complexity of the
sample, the relative percentage of the peptides and glycopeptides
present in the HILIC enriched fraction varied in a solvent dependent
manner. d–f Venn diagram showing the overlap of various peptides
present in the HILIC enriched fraction. Different subsets of overlapping
and distinct peptides were co-enriched in a solvent dependent manner
indicating that sample solvation plays a major role in HILIC enrichment
in addition to hydrophilic partitioning
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the applied mobile phase but also on the peptide backbone
composition. ACN provided the least number of co-enriched
peptides while IPA and ethanol showed some preferable fea-
tures when larger, hydrophobic glycopeptides needed to be
enriched. To the best of our knowledge, this is the first study
to systematically investigate the effect the mobile phase has on
ZIC-HILIC glycopeptide enrichment. Implementation of or-
thogonal mobile phase solvents provides one opportunity to
increase glycopeptide enrichment efficiency of ZIC-HILIC.
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